[Clinical effects of labetalol in 21 patients with phaeochromocytoma (author's transl)].
作者信息
Yoshinaga K, Arakawa K, Ikeda M, Ebihara T, Oe N
出版信息
Horumon To Rinsho. 1981 Apr;29(4):515-22.
PMID:7296922
Abstract
摘要
相似文献
1
[Clinical effects of labetalol in 21 patients with phaeochromocytoma (author's transl)].拉贝洛尔对21例嗜铬细胞瘤患者的临床疗效（作者译）
Horumon To Rinsho. 1981 Apr;29(4):515-22.
2
[Clinical effects of labetalol on pheochromocytoma].拉贝洛尔对嗜铬细胞瘤的临床疗效
Horumon To Rinsho. 1983 Feb;31(2):183-92.
3
[Malignant pheochromocytoma: blood pressure controlled by labetalol].[恶性嗜铬细胞瘤：拉贝洛尔控制血压]
Nihon Hinyokika Gakkai Zasshi. 1984 Mar;75(3):523-7.
4
Effect of labetalol on blood pressure and plasma catecholamine concentrations in patients with phaeochromocytoma.拉贝洛尔对嗜铬细胞瘤患者血压和血浆儿茶酚胺浓度的影响。
Br Med J. 1980 May 31;280(6227):1300-1. doi: 10.1136/bmj.280.6227.1300-a.
5
[Pheochromocytoma treated with combined alpha-beta blockader].[联合使用α-β受体阻滞剂治疗嗜铬细胞瘤]
Lakartidningen. 1979 Jun 6;76(23):2248-50.
6
Hypertensive response to labetalol in phaeochromocytoma.
Lancet. 1978 May 13;1(8072):1045-6. doi: 10.1016/s0140-6736(78)90772-9.
7
Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol.用拉贝洛尔治疗嗜铬细胞瘤和可乐定撤药后高血压。
Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):809-15.
8
Labetalol and phaeochromocytoma.
Br J Anaesth. 1984 Oct;56(10):1179. doi: 10.1093/bja/56.10.1179.
9
[Labetalol in the intraoperative control of pheochromocytoma].
Lijec Vjesn. 1983 Jul-Aug;105(7-8):304-6.
10
Labetalol in the preoperative management of phaeochromocytoma.拉贝洛尔在嗜铬细胞瘤术前管理中的应用
Anaesth Intensive Care. 1982 May;10(2):160-3. doi: 10.1177/0310057X8201000216.
Zotero 插件